Contact us Demo our platform

Blog

The Relationship Between Oxysterols, Disease States, and Inflammatory Responses

oxysterols-impact-disease-states

Oxysterols are bioactive lipids formed from the oxidation of cholesterol.1 Once formed, oxysterols can induce the expression and synthesis of chemokines, inflammatory cytokines, and adhesion molecules, all of which can contribute to inflammatory responses.1 These inflammatory responses thus provide a link between oxysterols and disease pathogenesis.2

Studies have documented oxysterols as a contributor to a gamut of diseases, such as atherosclerosis, Alzheimer’s disease, age-onset macular degeneration, cardiovascular diseases, diabetes, infertility, multiple sclerosis, Niemann-Pick disease type C, osteoporosis, Parkinson’s disease, and cancers.3 Oxysterol derangement can thus pose a danger to human health, and exploring oxysterols could offer new insights into disease etiology.

Atherosclerosis

High levels of oxysterols can contribute to atherosclerosis, the buildup of plaque inside artery walls that decreases blood flow.4,5

Alzheimer’s Disease

A progressive neurologic disorder, Alzheimer’s disease results in lost memory and impaired mental function. Oxysterols have been implicated in the progression of Alzheimer’s disease through their regulation of cholesterol synthesis and modulation of inflammatory responses.6

Infertility

Research documented a correlation of oxysterols to infertility based on data showing that infertile men have substantially higher levels of cholesterol in sperm membranes than fertile men.7 Thus, understanding the regulation of sterol synthesis offers an opportunity for research about male fertility.

Multiple Sclerosis

Multiple sclerosis occurs when the immune system targets myelin, the insulating sheath around nerve fibers, resulting in nerve damage and deterioration, thus disrupting transmission of signals along nerve axons. Research has linked the oxysterol, 24-hydroxycholesterol, to multiple sclerosis and other neurodegenerative diseases.8

Osteoporosis

Osteoporosis, a skeletal disorder characterized by low bone mass, can be partially caused by inflammation, triggered by oxysterols.9

Cancers

Cancer manifests when cells begin to grow uncontrollably. Oxysterols can influence tumor growth due to their immune modulating actions.10

Research Implications of Oxysterols

Leveraging oxysterols in research could drive the next wave of developing new therapies, diagnostic processes, and prediction methodologies for various diseases.

Ready to see what new insights oxysterols can help your research reveal?
Contact us today to discuss your project or study.

References

1. Brzeska, M., Szymczyk, K., Szterk, A. Current Knowledge about Oxysterols: A Review. Journal of food science. 2016; 81: 2299-2308. DOI: https://doi.org/10.1111/1750-3841.13423

2. Poli G, Biasi F, Leonarduzzi G. Oxysterols in the pathogenesis of major chronic diseases. Redox Biol. 2013; 1(1): 125–30.

3. Samadi A, Sabuncuoglu S, Samadi M, Isikhan SY, Chirumbolo S, Peana M, Lay I, Yalcinkaya A, Bjørklund G. A Comprehensive Review on Oxysterols and Related Diseases. Curr Med Chem. 2021; 28(1): 110-136. doi: 10.2174/0929867327666200316142659.

4. Meynier A, Lherminier J, Demaison-Meloche J, Ginies C, Grandgirard A, Demaison L. Effects of dietary oxysterols on coronary arteries in hyperlipidaemic hamsters. Br J Nutr. 2002; 87(5): 447–58.

5. de Freitas FA, Levy D, Reichert CO, Cunha-Neto E, Kalil J, Bydlowski SP. Effects of Oxysterols on Immune Cells and Related Diseases. Cells. 2022; 11(8): 1251. https://doi.org/10.3390/cells11081251

6. Lathe, R.; Sapronova, A.; Kotelevtsev, Y. Atherosclerosis and alzheimer—Diseases with a common cause? Inflammation, oxysterols, vasculature. BMC Geriatr. 2014; 14: 36.

7. Garolla, A.; Šabović, I.; Tescari, S.; De Toni, L.; Mene-gazzo, M.; Cosci, I.; De Filippis, V.; Giarola, M.; Foresta, C. Impaired sperm function in infertile men relies on the membrane sterol pattern. Andrology. 2018; 6(2): 325-334. http://dx.doi.org/10.1111/andr.12468 PMID: 29378089

8. Teunissen, C.E.; Dijkstra, C.D.; Polman, C.H.; Hoogervorst, E.L.; von Bergmann, K.; Lütjohann, D. Decreased levels of the brain specific 24s-hydroxycholesterol and cholesterol precursors in serum of multiple sclerosis patients. Neurosci Lett. 2003; 347: 159–162.

9. Zarrouk, A., Vejux, A., Mackrill, J., O’Callaghan, Y., Hammami, M., O’Brien, N., & Lizard, G. Involvement of oxysterols in age-related diseases and ageing processes. Ageing research reviews. 2014; 18: 148-162.

10. Traversari, C., Sozzani, S., Steffensen, K. R., & Russo, V. (2014). LXR‐dependent and‐independent effects of oxysterols on immunity and tumor growth. European journal of immunology. 2014; 44(7): 1896-1903.

Deirdre Hauser
Deirdre Hauser is the manager of the Clinical and Targeted Analysis Method Development Team, and the technical supervisor of Metabolon's CAP/CLIA compliant quantitative diagnostic testing laboratory. She has over 20 years of LC-MS/MS method development and validation experience with both endogenous and exogenous analytes.

Topics

Cardiovascular | Inflammation | Neurology | Oncology

Share this article

Related Blog Posts

See All Blog Posts

GET STARTED

Talk with an expert

Request a quote, get detailed information on sample types, or learn how metabolomics can accelerate your research. Find our contact details are here.

Find us on:

Talk with a Metabolomics expert

✕

References

1. Zgoda-Pols, J.R., et al., Metabolomics analysis reveals elevation of 3-indoxyl sulfate in plasma and brain during chemically-induced acute kidney injury in mice: investigation of nicotinic acid receptor agonists. Toxicol Appl Pharmacol, 2011. 255(1): p. 48-56.

2. Bryant, J.A., et al., The impact of an oral purified microbiome therapeutic on the gastrointestinal microbiome. Nat Med, 2026. 32(1): p. 186-196

3. McGovern, B .H., et al., SER-109, an Investigational Microbiome Drugto Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial. Clin Infect Dis, 2021. 72(12): p. 2132-2140.

4. Feuerstadt, P., et al., SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection. N Engl J Med, 2022. 386(3): p. 220-229.

5. Hu, Z., et al., Targeted metabolomics reveals novel diagnostic biomarkers for colorectal cancer. Mol Oncol, 2025. 19(6): p. 1737-1750.

6. Butler, F.M., et al., Vegetarian Dietary Patterns and Diet-Related Metabolites Are Associated With Kidney Function in the Adventist Health Study-2 Cohort. J Ren Nutr, 2025.

7. Stanford, J., et al., Metabolomic Profiling and Diet Quality Scoring in a Randomized Crossover Trial of Healthy and Typical Dietary Patterns. Mol Nutr Food Res, 2025 . 69(23): p. e70271.

8. O’Connor, L.E., et al., Metabolomic Profiling of an Ultraprocessed Dietary Pattern in a Domiciled Randomized Controlled Crossover Feeding Trial. J Nutr, 2023. 153(8): p. 2181-2192.

9. Fritsch, D.A., et al., Microbiome function underpins the efficacy of a fiber-supplemented dietary intervention in dogs with chronic large bowel diarrhea. BMC Vet Res, 2022. 18(1): p. 245.

10. Leal, L.N., et al., Preweaning nutrient supply improves lactation productivity and reduces the risk of culling in Holstein cows. J Dairy Sci, 2025. 108(6): p. 5875-5888.

11. Ahsin, M., et al., Soil and pasture health underlie improved beef nutrient density determined by untargeted metabolomics in Southern US grass finished beef systems. NPJ Sci Food, 2025. 9(1): p. 151.

12. Yin, W., et al., Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia. J Lipid Res, 2012. 53(1): p. 51-65.

13. Porter, F .D., et al., Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci Transl Med, 2010. 2(56): p. 56ra81.

14. Needham, B .D., et al., Plasma and Fecal Metabolite Profiles in Autism Spectrum Disorder. Biol Psychiatry, 2021. 89(5): p. 451-462

15. Li, C., et al., Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells. J Exp Med, 2014. 211(1): p. 15-28.

16. Green, P.G., et al., Metabolic flexibility and reverse remodelling of the failing human heart. Eur Heart J, 2025. 46(25): p. 2422-2433.

17. Maekawa, H., et al., SGLT2 inhibition protects kidney function by SAM-dependent epigenetic repression of inflammatory genes under metabolic stress. J Clin Invest, 2025. 135(19).

18. Wu, D., et al., Integrated screens reveal that guanine nucleotide depletion, which is irreversible via targeting IMPDH2, inhibits pancreatic cancer and potentiates KRAS inhibition. Gut, 2026.

19. Schwerdtfeger, L.A., et al., Gut microbiota and metabolites are linked to disease progression in multiple sclerosis. Cell Rep Med, 2025. 6(4): p. 102055.

20. Wu, H., et al., Microbiome-metabolome dynamics associated with impaired glucose control and responses to lifestyle changes. Nat Med, 2025. 31(7): p. 2222-2231.

21. Jacobs, J.P., et al., Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement. Microbiome, 2021. 9(1): p. 236.

22. Pietzner, M., et al., Plasma metabolites to profile pathways in noncommunicable disease multimorbidity. Nat Med, 2021. 27(3): p. 471-479.

23. Faquih, T.O., et al., Robust Metabolomic Age Prediction Based on a Wide Selection of Metabolites. J Gerontol A Biol Sci Med Sci, 2025. 80(3).

24. Scherer, N., et al., Coupling metabolomics and exome sequencing reveals graded effects of rare damaging heterozygous variants on gene function and human traits. Nat Genet, 2025. 57(1): p. 193-205.

25. Holmes, Z.C., et al., Untargeted metabolomic analysis of human milk from healthy mothers reveals drivers of metabolite variability. Sci Rep, 2024. 14(1): p. 20827.

26. Titz, B., et al., Implications of Ocular Confounding Factors for Aqueous Humor Proteomic and Metabolomic Analyses in Retinal Diseases. Transl Vis Sci Technol, 2024. 13(6): p. 17.

27. Bloom, S.M., et al., Cysteine dependence of Lactobacillus iners is a potential therapeutic target for vaginal microbiota modulation. Nat Microbiol, 2022. 7(3): p. 434-450.

28. Leimer, E.M., et al., Lipid profile of human synovial fluid following intra-articular ankle fracture. J Orthop Res, 2017. 35(3): p. 657-666.